| Product Name | Abiraterone Isopropyl Ether;AB-IMP-13 |
|---|---|
| CAS | 2484719-15-3 |
| Formula | C27H37NO |
| MW | 391.59 |
| Appearance | White to off-white solid |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 2 mg | In-stock | $166.00 | Visible after login | |
| 5 mg | In-stock | $266.00 | Visible after login | |
| 10 mg | In-stock | $436.00 | Visible after login |
| Product Name | Abiraterone Isopropyl Ether;AB-IMP-13 |
|---|---|
| CAS | 2484719-15-3 |
| Formula | C27H37NO |
| MW | 391.59 |
| Appearance | White to off-white solid |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Abiraterone Isopropyl Ether is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17, 20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.